Huadong Medicine’s latest announcement: plans to acquire 60% equity of Huaren Technology for no more than 396 million yuan
Wuhu Huaren is a functional chemical research and development company, mainly engaged in the development of a series of nucleoside phosphoramidite monomers, nucleosides and nucleotides and their modifications, heterocyclic and carbohydrate compounds, and new-generation antiviral drug intermediates. Development, production and sales. Recently, Huadong Medicine plans to invest no more than 396 million yuan to acquire […]